Seed Media Group

Terra Sigillata

musings on medicines from the Earth

Search this blog

Profile

Abel%20sharpened%20reduced%20150px.jpg Abel Pharmboy is the nom de plume of an academic researcher and educator who holds a PhD in Pharmacology. He writes on natural product drugs and dietary supplements, academic career development, medical journalism and, occasionally, making and listening to music and, with the help of his colleague, Erleichda, wine appreciation.

Terra Sigillata is the name of the first authenticated, trademarked drug. "Why Terra Sigillata?" will tell you more about the origin of the blog name.

You can learn quickly the distinction between the fields of Pharmacology, Pharmacognosy, Pharmacy, the Pharmaceutical Sciences by clicking on the hyperlinks.

Learn more about the author and the origin of "Abel Pharmboy" here.

Please feel free to contact me off-blog by e-mail to abelpharmboy (at) gmail (dot) com.

Please read the DISCLAIMER for details on the blog's intended audience, advertising and comment policy, and how not to use the information presented herein.

DonorsChoose 2008


We comply with the HONcode standard for trustworthy health
information:
verify here.

 Subscribe in a reader

Add to Google Reader or Homepage

Subscribe in NewsGator Online

Subscribe in Bloglines

http://www.wikio.com


OpenLab2006.png Openlab 2007

Recent Posts

Recent Comments

Subscribe via Email

Stay abreast of your favorite bloggers' latest and greatest via e-mail, via a daily digest.

Sign me up!

Archives

Blogroll

« Another warning on "chelation therapy" | Main | About Erleichda, co-author of The Friday Fermentable »

First anniversary of DrugMonkey

Category: Blogging communityCareer developmentGraduate EducationNeuroscienceResearchResearch funding
Posted on: January 18, 2008 12:02 PM, by Abel Pharmboy

We're a little bit late here in wishing the DrugMonkey blog a happy 1st blogiversary. Contributors DrugMonkey, BikeMonkey, and PhysioProf have had a very productive year of offering valuable career advice for graduate and postgraduate trainees in the biomedical sciences, general discussions on NIH grant funding, and various topics in neuroscience.

The sci/med blogosphere is populated quite heavily by graduate students, medical students, and postdoctoral fellows. This situation is perhaps easy to explain in that most of these trainees are of an age that is comfortable with social networking and public discussions via the intertubes. For some reasons not entirely clear to me, physicians are exceptions to this rule and we see doc bloggers across the spectrum from residents and fellows to full profs, and from academia to private practice.

However, NIH/NSF/other-big-agency grant-funded PhD researchers who spend most of their bandwidth talking about the business of conducting biomedical research are less frequently found as bloggers; DrugMonkey is one of the few out there. And again, for reasons not entirely clear to me, the other ones out there are primarily women, such as FemaleScienceProfessor.

Here's a good example of the value readers find in the discussions over there:

I read for grant[s]manship and career advice. I've been reading your blog over my transition from postdoc to asst prof (including during the interview process). You guys have helped me out immensely that's why I keep coming back... I continue to LearnSomething.

That's a pretty sweet endorsement.

However, some commenters over at DrugMonkey, particularly trainees, have complained that the posts there often "ranked on" trainees. But upon closer analysis of that particular post, the content there is presented in the spirit of helping trainees with the advancement of their careers, regardless of how unpleasant the realities of this career track might seem.

I would've killed as a graduate student or postdoc for insightful posts such as advice for the disgruntled trainee, influence of your CV on getting faculty position interviews, pointers on how to interview for a faculty position, or an inside look at how grant review panels examine specific aspects of research proposals.

Making it to one year is a big deal for a blog; a year of regular posting by a scientist means that you have made a real commitment and consider your blogging important to your role as a member of the scientific community. I have grown to appreciate what the folks are doing over at DrugMonkey and encourage trainees and practicing scientists alike to dial them up regularly. And, hey, go wish them a happy blogiversary and answer their questions in the comments.

No, this business isn't always pretty. But at least we're not in the consumer loan industry.

Congratulations, gents.

Comments

geez Abel, thanks!

Actually I'm jumping the gun a bit, that wasn't exactly a first anniversary post, there's a couple of weeks to go yet. I think I'll make it though!

More like a run-up on the new year of blogging. Artificial but as I'm sure you know, as good a time as any to do some musing on direction, audience, etc.

Posted by: Drugmonkey | January 18, 2008 12:38 PM

Thanks, dude!

Posted by: PhysioProf | January 18, 2008 2:34 PM

Thanks for putting props where props are due. DM has been a valuable blogging mentor for me.

Posted by: Thomas Robey | January 18, 2008 11:21 PM

Same here.

Posted by: PhysioProf | January 19, 2008 4:33 PM

Post a Comment

(Email is required for authentication purposes only. Comments are moderated for spam, your comment may not appear immediately. Thanks for waiting.)





Having problems commenting? (UPDATED)

Blogs in the Network

Advertisement

Top Five: Readers' Picks

Search All Blogs